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Abstract
Insulin increases cellular glucose uptake and metabolism in the postprandial state by acutely stimulating the translocation
of the Glut4 glucose transporter from intracellular membrane compartments to the cell surface in muscle and fat cells. The
intracellular targeting of Glut4 is dictated by specific structural motifs within cytoplasmic domains of the transporter. We
demonstrate that two leucine residues at the extreme C-terminus of Glut4 are critical components of a motif (IRM, insulin
responsive motif) involved in the sorting of the transporter to insulin responsive vesicles in 3T3L1 adipocytes. Light
microscopy, immunogold electron microscopy, subcellular fractionation, and sedimentation analysis indicate that mutations
in the IRM cause the aberrant targeting of Glut4 to large dispersed membrane vesicles that are not insulin responsive.
Proteomic characterization of rapidly and slowly sedimenting membrane vesicles (RSVs and SSVs) that were highly enriched
by immunoadsorption for either wild-type Glut4 or an IRM mutant revealed that the major vesicle fraction containing the
mutant transporter (IRM-RSVs) possessed a relatively small and highly distinct protein population that was enriched for
proteins associated with stress granules. We suggest that the IRM is critical for an early step in the sorting of Glut4 to insulinresponsive subcellular membrane compartments and that IRM mutants are miss-targeted to relatively large, amorphous
membrane vesicles that may be involved in a degradation pathway for miss-targeted or miss-folded proteins or represent a
transitional membrane compartment that Glut4 traverses en route to insulin responsive storage compartments.
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been detected in several distinct intracellular membrane compartments, including endosomes, the trans-Golgi reticulum, and what
appears to be a highly specialized membrane compartment that is
usually referred to as Glut4 storage vesicles (GSVs) [16,17,18]. It is
believed that in the basal state Glut4 moves among these
intracellular compartments via vesicular-mediated budding and
fusion events [18,19]. Very little Glut4 can be detected in the
adipocyte plasma membrane in the basal state [12,13,19,20].
There is disagreement as to whether Glut4 recycles through the
plasma membrane in the absence of insulin, and the extent to
which recycling occurs may be dependent on the specific
experimental conditions used, at least in 3T3-L1 adipocytes
[14,21,22].
Although the precise subcellular itinerary that Glut4 follows
after its biosynthesis in adipocytes remains poorly understood, it is
generally agreed upon that very few other proteins share the
intracellular trafficking of this molecule [23]. This implies that
Glut4 possesses specific structural information that dictates its
unusual insulin-regulated subcellular trafficking, and many studies
have addressed this question over the past two decades
[24,25,26,27]. The complexity of Glut4 membrane trafficking
suggests that several distinct structural targeting motifs are likely to

Introduction
The rapid rise in circulating insulin levels after the ingestion of a
carbohydrate-containing meal stimulates glucose transport into fat
and muscle cells by causing the acute redistribution of the Glut4
glucose transporter from intracellular membrane storage compartments to the cell surface [1,2,3,4,5]. The resulting increase in
glucose catabolism and storage in the form of glycogen and fat in
these cells acts to buffer increases in blood glucose levels and
prevent protracted postprandial hyperglycemia. A defect in the
ability of Glut4 in muscle and fat cells to appropriately translocate
to the cell surface in response to elevated circulating insulin levels
is the proximal cause of peripheral insulin resistance [6,7], a
pathological state that is associated with obesity, metabolic
syndrome, and type 2 diabetes mellitus [8,9,10,11]. Consequently,
much effort has been expended in an attempt to understand the
molecular mechanism by which insulin regulates the subcellular
trafficking of Glut4 and the possible derangements in this process
that may result in insulin resistance.
The subcellular trafficking of Glut4 has been most thoroughly
studied in cultured primary rat adipocytes and in the murine 3T3L1 adipocyte cell line [12,13,14,15]. Under steady-state basal
conditions, i.e., in the absence of insulin, the bulk of Glut4 has
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MO). Polyclonal antibody against hemaglutinin (HA) was
purchased from Abcam (Cambridge, MA). Monoclonal antibody
against HA was purchased from Covance (Berkeley, CA). The
Glut4 polycolonal antibody was described previously (Song et al.).
Polyclonal antibody against Dsred was from Clontech (Mountain
view, CA), Polyclonal antibody against G3bp1 was from Bethyl
Laboratories (Montgomery, TX), Polyclonal antibody against
G3bp2 was from LSBio (Seattle, WA). Rabbit IgG antibody was
from Bethyl (Montgomery, TX). Colloidal Gold-affiniPure Goat
anti-rat or mouse IgG were from Jackson ImmunoResearch (West
Grove, PA).

be involved in this process, and experimental evidence is consistent
with this assumption [28,29,30,31,32]. Several putative Glut4
trafficking motifs have been identified, including a di-leucine
motif, a TELEY motif, and the IRM motif, all localized to the
cytoplasmic carboxyl terminal domain [32,33,34,35]. An FQQI
targeting motif has been identified within the N-terminal
cytoplasmic domain [36,37], and undefined structural information
within the central cytoplasmic loop of Glut4 appears to be crucial
for the intracellular trafficking of newly synthesized molecules
[38]. The specific phenotypes exhibited by mutations in these
various putative trafficking motifs appear to vary depending on cell
type and specific experimental conditions. A recent study in
3T3L1 adipocytes suggests that the FQQI and the TELEY motifs
are involved in the intracellular retention of Glut4 in the basal
state via recycling between endosomal compartments and the
trans-Golgi network and GSVs, respectively [18,39]. Mutation of
either motif causes a partial redistribution of Glut4 to the cell
surface and thus blunts the relative magnitude of insulin-induced
redistribution to the cell surface. The di-leucine motif appears to
be involved in the rapid internalization of Glut4 from the cell
surface after insulin withdrawal [18].
Co-localization of wild type and mutant Glut4 molecules in
individual cells under basal conditions is consistent with the roles
proposed above for the 3 trafficking motifs. Mutant Glut4
molecules largely co-localize with wild-type Glut4, but in the case
of mutations in the FQQI and/or TELEY motifs, an increase in
cell surface localization is evident under basal conditions [18,32].
In contrast, mutations in the IRM motif, which partially overlaps
with the TELEY motif within the carboxy terminal cytoplasmic
tail of Glut4, totally abolish insulin-stimulated translocation of
Glut4 to the cell surface in addition to any detectable recycling of
Glut4 through the plasma membrane in the basal state. The bulk
of IRM mutant molecules are present in large dispersed
cytoplasmic vesicles (LDVs) that lack wild type Glut4 [34].
In this study we further investigate the role of the IRM in Glut4
trafficking. We demonstrate that the two leucine resides within the
IRM (L500 and L503) are critical for the appropriate subcellular
trafficking of Glut4. Six different single or double point mutations
involving either or both of these residues resulted in the mistargeting of Glut4 similar to that observed for the original IRM
mutant. In contrast to wild-type Glut4, The IRM mutant was
heavily enriched in rapidly sedimenting vesicles after subcellular
fractionation of 3T3L1 adipocytes. Immunogold electron microscopy indicated a high concentration of the IRM mutant in 150–
250 nm vesicles that were closely associated with many unlabeled,
smaller vesicles. Lastly, a sensitive proteomics analysis of immunoenriched vesicles containing either wild type Glut4 or the IRM
mutant demonstrated highly divergent protein compositions,
suggesting that mutations in the IRM divert Glut4 to a ‘‘deadend’’ trafficking pathway whereby Glut4 is unable to reach insulinresponsible membrane compartments.

Cell Culture
3T3L1 fibroblasts (from American Tissue Type Culture
Collection, Virginia) were grown in 20% calf serum in DMEM
containing 25 mM glucose and supplemented with 10% glutamate, 1% penicillin, and 1% streptomycin. Two days after
achieving confluence, the medium was changed to FBS medium
(10% fetal bovine serum in DMEM supplemented with 10%
glutamine and 1% penicillin and 1% streptomycin) with the
addition of 670 nM insulin, 0.5 mM 3 isobutyl-methylxanthine,
and 25 nM dexamethasome) for 2 days, and then replaced with
FBS medium containing 670 nM insulin. After 48 hours, the
differentiated cells were incubated in FBS medium, the cells were
infected with adenovirus at day 5–6 overnight, and the adipocytes
were then analyzed between days 8–10.

Expression of Glut4 Constructs in 3T3-L1 Adipocytes
3T3-L1 adipocytes were infected with recombinant adenoviruses encoding Glut4 constructs as described in detail previously
[34]. Large-scale viral stocks were routinely titered to determine
the appropriate quantities required to equalize expression levels
among the different constructs.

Immunofluorescence Microscopy
3T3-L1 adipocytes were serum-starved for 2 hours, treated with
or without 1 mM insulin for 30 minutes, washed with ice cold PBS
buffer, and then fixed in 4% formaldehyde for 15 minutes at room
temperature. The cover slips were washed with PBS for
15 minutes, incubated with primary anti-HA antibody or antiG3bp1 antibody (Sigma-Aldrich, St. Louis, MO) and seconday
antibodies (see ref 35). After mounting in Vectashield medium
(Vector Laboratories, Inc. Burlinggame, CA) on glass slides,
fluorescence images of the protein were then recorded using a
ZEISS LSM-510 META laser confocal image system (Carl Zeiss,
Thornwood, NY).

Subcellular Fractionation and Sucrose Velocity Gradient
Analysis
Adenovirus infected or uninfected 3T3-L1 adipocytes were
serum starved overnight at day 8–9 post-differentiation. After
washing 3x with cold PBS buffer, the cells were scraped into icecold HES buffer (50 mM Hepes, pH 7.4, 0.25M sucrose, 1 mM
EDTA) containing a mixture of protease inhibitors (1 mg/ml
leupeptin, 1 mg/ml benzamidine, 1 mg/ml chymostatin, 1 mg/ml
pepstatin A, 5 mg/ml trypsin inhibitory, 0.082 units/ml aprotinin),
and phosphatase inhibitor cocktail 2 (Sigma), homogenized, and
then subjected to subcellular fractionation as described previously
(Song et al, 2008). The SSV (formerly called LDM) and RSV
(formerly called HDM) membrane fractions were resuspended in
HES buffer and layered on top of a 10–30% linear sucrose
gradient. The samples were centrifuged at 35,000 rpm for 1 hour
at 4uC in a Beckman SW41 rotor, and 13 fractions were collected

Materials and Methods
Chemicals and Antibodies
DMEM and calf serum were purchased from Gibco. Fetal calf
serum was purchased from ATLANTA biologicals (Lawrenceville,
GA). BCA protein assay kits were purchased from Pierce
(Rockford, Ll). RapiGest was from Waters (Milford, MA).
Lipofectamin RNAiMAX Reagent, G3bp1 siRNA products
‘‘ggaacuuucuaugaucaga’’ and ‘‘agccuguaguggaaccaga’’, G3bp2
siRNA ‘‘gaaugaugcgugaucguga’’ and ‘‘ggaaguuuaugcaaaccuu’’,
negative control#1 siRNA were from Life Technologies (Grand
island, NY). All other chemicals from Sigma-Aldrich (St. Louis,
PLOS ONE | www.plosone.org
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from the bottom of the tube. Equal amounts of the fractions were
then subjected to SDS-PAGE.

High-resolution Nano-LC-MS
Peptide mixtures were analyzed using high-resolution nano-LCMS on a hybrid mass spectrometer consisting of a linear
quadrupole ion-trap and an Orbitrap (LTQ-Orbitrap XL,
Thermo Fisher Scientific). Chromatographic separations were
performed using a nanoLC 2D PlusTM (Eksigent) for gradient
delivery and a cHiPLC-nanoflex (Eksigent) equipped with a 15 cm
675 mm C18 column (ChromXP C18-CL, 3 mm, 120 Å,
Eksigent). The liquid chromatograph was interfaced to the mass
spectrometer with a nanospray source (PicoView PV550; New
Objective). Mobile phases were 1% FA in water (A) and 1% FA in
acetonitrile (B). After equilibrating the column in 98% solvent A
(aqueous 1% FA) and 2% of solvent B (acetonitrile containing 1%
FA), the samples (5 ml) were injected from autosampler vials using
the LC-system’s autosampler at a flow rate of 500 nl/min followed
by gradient elution (250 nl/min) with solvent B: isocratic at 2% B,
0–5 min; 2% B to 25% B, 5–110 min; 25% to 80%, 110–170 min;
80% to 2%, 170–175; and isocratic at 2% B, 175–190 min. Total
run time, including column equilibration, sample loading, and
analysis was 217 min. The maximum injection times for the MS1
scan in the Orbitrap and the LTQ were both 500 ms, and the
maximum injection times for the MSn scan in the Orbitrap and
the LTQ were 500 ms and 1000 ms respectively. The automatic
gain control targets for the Orbitrap and the LTQ were 26105
and 36104 respectively, for the MS1 scans and for the MSn scan
were 16105 and 16104 respectively. The MS1 scans were
followed by six MS2 events in the linear ion trap with collision
activation in the ion trap (parent threshold = 1000; isolation width
= 2.0 Da; normalized collision energy = 30%; activation Q
= 0.250; activation time = 30 ms). Dynamic exclusion was used to
remove selected precursor ions (20.20/+1.0 Da) for 90 s after
MS2 acquisition. A repeat count of 1, a repeat duration of 45 s,
and a maximum exclusion list size of 500 was used. The following
ion source parameters were used: capillary temperature 200uC,
source voltage 4.0 Kv, source current 100 uA, and the tube lens at
110 V. The data were acquired using Xcalibur, version 2.0.7
(Thermo Fisher).

Immuno-isolation of Glut4 and IRM mutant membrane
vesicles
Antibodies against Glut4 or Dsred were crosslinked to protein A
Dynabeads (from Invitrogen, Carlsbad, CA) with 20 mM
dimethylpimelimidate (Pierce) in 0.2 M triethanolamine (pH 8.2)
for 30 minutes at room temperature. After quenching with 50 mM
Tris (pH 7.5) for 15 minutes, the beads were washed with PBS.
1.5 mg of RSV or SSV protein from IRM/Glut4 adenovirus
infected adipocytes or control adipocytes were resuspended in ice
cold IC buffer (140 mM potassium glutamate, 20 mM Hepes,
pH 7.4, 1 mM EGTA, 5 mM NaCl, 1 mM DTT) with protease
inhibitors (1 mg/ml leupeptin, 1 mg/ml benzamidine, 1 mg/ml
chymostatin, 1 mg/ml pepstatin A, 5 mg/ml trypsin inhibitory,
0.082 trypsin inhibitory units/ml aprotinin), and phosphatase
inhibitor cocktail 2 (sigma), incubated with Dynabeads covalently
conjugated to anti-Glut4 polyclonal antibody (for IRM/Glut4
expressing cells) or anti-rabbit IgG (for control cells) overnight at
4uC. The resulting supernatant was incubated with Dynabeads
covalently conjugated with anti-Dsred polyclonal antibody (for
IRM/Glut4 expressed cells) or rabbit IgG (for control cells)
overnight at 4uC. The resulting beads were subsequently washed
with IC buffer 5 times, and the proteins were then eluted with
sample buffer containing 2% RapiGest, 100 mM Tris (PH 8.5),
16 reductant (Biorad, Hercules, CA).

Protein Endoprotease Digestion and Peptide Preparation
The eluates from the bead immunoprecipitates were precipitated using the vendor protocol for the 2D clean-up kit (GE
Healthcare, Pittsburgh, PA, Cat. No. 80–6484–51). The protein
pellets were solubilized in 20 ml of Tris buffer (100 mM, pH 8.5)
containing 8 M urea. The protein disulfide bonds were reduced
with 1 mM TCEP (2 ml of a 50 mM solution) (TCEP bond
breaker, 0.5 M solution, Thermo Fisher, Waltham, MA, Cat No.
77720) and placed at room temperature for 30 min. Alkylation of
the cysteine residues was performed using iodoacetamide (2.2 ml of
a 100 mM solution). After 30 min at room temperature in the
dark, the reaction was quenched with 10 mM DTT at room
temperature for 15 min. The reduced alkylated proteins (,30 ml)
were digested in 8 M urea with 1 mg of endoproteinase Lys-C (2 ml
of a 0.5 mg/ml stock; Roche, Basel, Switzerland) after an overnight
incubation at 37uC. The samples were diluted 1:4 with 100 mM
Tris, pH 8.5, trypsin (Sigma, Cat No. T6567) was added (,1:4
enzyme ratio), and the incubation was continued for 24 h at 37uC.
The digests were acidified with aqueous 5% formic acid (3.3 ml)
(Fluka, St. Louis, MO, Cat No. 56302). The peptides were
extracted with a conditioned Nutip carbon tip (Glygen, Columbia,
MD) (Cat No. NT3CAR). The tips were prepared by repetitive
pipetting with 25 ml (63) of the peptide elution solvent (60%
acetonitrile in 1% formic acid and then equilibrated with 10
washes (25 ml) of extraction solvent (1% formic acid). The sample
was loaded with 50 pipetting cycles. The tips were then washed
four times with extraction solution. The peptides were recovered
by 20 pipetting cycles with 25 ml of elution solution, followed by
four washes (20 ml each) of elution solution. The extraction and
wash solutions were combined in an autosampler vial (SunSri,
Rockwood, TN, Cat No. 200 046) and dried in a Speed Vac
(Thermo-Savant). The vial caps for the AS2 autosampler was from
National Scientific (Rockwood, TN, Cat. No. 03–396AA).

PLOS ONE | www.plosone.org

MS Data Processing and Protein Quantification
The LC-MS data processing pipeline is detailed in Figure S2.
For protein identification, the LC-MS/MS files that were acquired
using Xcalibur were processed using Mascot Distiller software (ver
2.0.3) for the preparation of files for database searching. A
UNIPROT mouse protein database (downloaded May 2011, with
135387 sequences) with an added bovine serum albumin sequence
(Uniprot accession No., P02769) was searched using Mascot
software (ver. 2.2.04) with the parameters previously described
(Morales DM et al (2011) Molecular and Cellular Proteomics (see
Figure 1). The protein database searches were further processed
using Scaffold software (ver. 3_00_07) and the proteins were
identified using the Protein Prophet algorithm [40] with protein
and peptide thresholds of 95% and 50%, respectively. The
identified peptide sequences and mass spectrometric data that
were used for protein identifications are given in Table S4.
For relative protein quantification, the LC-MS unprocessed files
were imported into Rosetta ElucidatorTM (Rosetta Biosoftware,
ver 3.3) for retention time alignment of the peptide ion currents
across the chromatographic time window using previouslydescribed parameters [41] that are detailed in Figure S1. The
aligned, normalized peptide ion currents were annotated within
the alignment software by generating database search files (*.dta)
and were annotated at the feature level of the software. By
correlating the protein identifications with the Protein Prophet
criteria used in Scaffold, as stated above. The ion current signals
3
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Figure 1. Diagrams of the IRAP and Glut4 sequence alignment used to identify the IRM mutant constructs. (A) Sequence alignment
between the C-terminus of Glut4 and the N-terminus of IRAP; (B) HA/IRM and IRM/Dsred were tagged with the HA epitope within its first exofacial
loop. Glut4/eGFP and all other mutants were tagged with GFP or Dsred at their C-termini. Amino acid residues are designated by the single-letter
code. The gray and underlined letters are the amino acids that were mutated to alanine residues.
doi:10.1371/journal.pone.0068516.g001

from all charge states for each peptide were concatenated unique
using a visual script within the software. The table of peptides and
peptide intensities was exported in Excel *.csv format. The
peptides were grouped as individual genes. The gene-grouped and
peptide intensity data were imported into DanTE-R for statistical
analysis [42,43].

IF8 mouse monoclonal or anti-rat Dsred or control IgG antibody
for 30 minutes, washed with NaHCa buffer and then probed with
18 nm colloid gold-conjugated anti-mouse or 12 nm colloid-gold
conjugated anti-rat IgG for 30 minutes. After washing with
D2H2O, the samples were quickly frozen, freeze dried, and then
replicated with platinum. Imaging was conducted using a ‘‘JEOL
1400 microscope’’, and photographed with an AMT digital
camera.

Deep-etch Electron Microscopy
Glass chips were cleaned with Chromic Sulfuric acid and
ddH2O, carbon coated and glow discharged for 1 minute. After
incubation in 0.1 mg/ml protein A for 30 minutes at room
temperature and washing with PBS, the glass chips were blocked
with 1% BSA in PBS for 30 minutes, coated with polyclonal antiGlut4 or Dsred antibody or control anti-rabbit IgG for 1 hour at
room temperature (see figure S2). The chips were incubated with
SSV/RSV fraction or post Glut4 immuo-adsorbed RSV/SSV
fraction overnight at 4uC. After washing with PBS, the vesiclecaoated glass chips were fixed with 2% formaldehyde in buffer
containing 70 mM KCl, 30 mM Hepes, 5 mM MgCl2 (pH 7.2),
3 mM EGTA. After fixation for 15 minutes at room temperature,
the chips were quenched with NaHCa buffer (100 mM NaCl,
30 mM Hepes, 2 mM CaCl2), plus 50 mM Lysine, 50 mM
glycine and 50 mM NH4Cl for 30 minutes at room temperature.
The chips were blocked with 1% BSA for 30 minutes, probed with
PLOS ONE | www.plosone.org

Results
We previously noted the presence of sequence similarity
between the extreme cytoplasmic C- terminal tail of Glut4 and a
region within the amino terminus of the insulin responsive amino
peptidase (IRAP), two membrane proteins that appear to share a
major portion of their intracellular trafficking pathways in
adipocytes (see Figure 1a). Two different sets of mutations within
the IRM sequence motif (LXXLXPDEXD) were reported to
result in aberrant subcellular targeting of Glut4 in the basal state
and completely abolished its insulin-stimulated redistribution to
the plasma membrane [34]. The possibility remained, however,
that we had inadvertently introduced an unrelated and previously
undefined dominant trafficking motif at the carboxy terminus of
Glut4 in the two IRM mutants that were analyzed. We therefore
4
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examined the trafficking of 6 different single and double point
mutations within the IRM sequence involving L500, L503, and P505
(see Figure 1b). The red fluorescent protein-tagged mutants were
co-expressed in 3T3L1 adipocytes with green fluorescent proteintagged wild type Glut4 in order to directly assess co-localization of
the two different molecules within individual cells. We have
previously demonstrated that wild type Glut4 targets indistinguishably whether it is tagged at its carboxyl-terminus with GFP or
RFP, and that the tagged fusion proteins target very similarly to
endogenous IRAP in 3T3L1 adipocytes [34]. Figure 2 shows that
all 5 of the mutants in which either L500 and/or L503 were
changed to alanine residues displayed aberrant targeting in the
basal state compared to the wild type control, whereas the P505
mutant exhibited targeting that was indistinguishable from the
wild type control under these conditions. Likewise, insulinstimulated translocation of Glut4 to the cell periphery (representing presumptive plasma membrane insertion) was abolished in all
5 of the L500 and/or L503 mutants but remained intact in the single
P505 point mutant (Figure 3). As observed previously, a much
larger fraction of the aberrantly targeted mutants was present in
large, dispersed, amorphous vesicles compared to the tagged wildtype Glut4, which was largely observed in small, diffuse, punctate
structures and in a perinuclear compartment. Some co-localization
between the mutants and wild-type transporters was observed in
the perinuclear area.
The difference in targeting between the IRM mutant and wild
type Glut4 was also readily apparent after subcellular fractionation. A much higher fraction of mutant vesicles was present in the
rapidly sedimenting vesicle (RSV) fraction on a per mg total
protein basis versus the slowly sedimenting vesicle (SSV) fraction
compared to endogenous wild type Glut4 (Figure 4A). Note that
the IRM mutant is not recognized by the anti-Glut4 carboxyterminal peptide antibody that was used to detect the endogenous
wild type transporter. The SSV and RSV fractions were subjected
to sucrose velocity gradient centrifugation and the distributions of
endogenous wild-type Glut4 and the IRM mutant were determined across the gradients by quantitative immunoblot analysis.
The IRM was detected using an antibody against the hemaglutinin
tag placed in the first exofacial loop (see Figure 1). In the SSV
fraction wild type Glut4 and the IRM mutant were both present in
single peaks near the tops of the gradients, with the mutant peak
displaced slightly nearer to the top of the gradient compared to
wild type Glut4 (Figure 4B). In the RSV fraction wild type Glut4
was more heterogeneously distributed across the entire gradient
but was largely present in two peaks representing smaller vesicles
near the top of the gradient and larger vesicles near the bottom of
the gradient (Figure 4C). This suggests that smaller membrane
vesicles may have remained associated with larger vesicles during
the initial differential centrifugation, but were separated or derived
from the larger vesicles at some point before or during the linear
sucrose gradient centrifugation step. Our unpublished data
indicate that the small vesicles associated with the RSV fraction
are not a non-specific sampling of trapped small vesicles from the
SSV fraction, because they have a distinct protein composition (R.
Hresko and M. Mueckler, unpublished observations). In contrast,
the distribution of the IRM mutant in the RSV fraction was much
more heavily weighted towards larger vesicles near the bottom of
the gradient in comparison to wild type endogenous Glut4. These
observations are consistent with the striking qualitative differences
observed in the distribution of wild type Glut4 and the IRM
mutant via confocal immunofluorescence microscopy [34](also see
Figures 2 and 3), which showed that the IRM mutant is
concentrated in large, dispersed, cytoplasmic vesicles under both
basal and insulin-stimulated conditions.
PLOS ONE | www.plosone.org

Figure 2. L500 and L503 are critical for the targeting of Glut4 to
GSVs in the basal state. After co-expression of wild-type Glut4/eGFP
and the various mutants within the IRM region of Glut4/Dsred by
recombinant adenovirus infection, adipocytes were serum starved for
2 hours, washed with cold PBS, fixed with 4% paraformaldehyde, and
then subjected to confocal microscopy analysis. The red color on the
left panels represents mutants of Glut4/Dsred, the green color in the
middle panels represents wild type Glut4/eGFP, and the yellow color in
the right panels represents the colocalization of Glut4/eGFP and
mutated Glut4/Dsred. The images were taken approximately through
the middle of the cells and are representative of 4–5 independent
experiments. The scale bar represents 10 mm.
doi:10.1371/journal.pone.0068516.g002

SSV and RSV membrane fractions from 3T3L1 adipocytes
expressing the Dsred/HA-tagged IRM mutant were immunoadsorbed onto glass chips coated with anti-Glut4 or anti-Dsred
antibodies, subjected to secondary immunogold labeling after
incubation with anti-Glut4 or anti-Dsred antibodies, and then

5
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ectopically-expressed Dsred-tagged IRM mutant (Figure 5b).
The Glut4-adsorbed RSV fraction contained a mixture of small
(50–100 nm) free vesicles and larger vesicles (150–250 nm) that
often were associated with branching structures and smaller
vesicles (Figure 5c). Gold particles were observed on both small
and large, branching structures in this fraction. In contrast, the
Dsred-adsorbed RSV fraction contained a preponderance of
larger vesicles (100–250 nm), many of which were densely labeled
with gold particles directed against the IRM mutant (Figure 5d).
These data are consistent with the observations obtained using
light microscopy and subcellular fractionation. Interestingly, many
of the gold particles in the Glut4-RSV fraction were associated
with branching structures connected to larger vesicles, whereas
most of the gold particles in the IRM-RSV fraction were directly
associated with the bodies of large vesicles.
In a further effort to characterize the distinct membrane
compartments to which the IRM mutant was routed, vesicles
containing Glut4 or the IRM mutant were isolated from SSV and
RSV fractions by immunoadsorption using a magnetic bead
procedure. The magnetic bead procedure was critical to obtaining
highly enriched vesicles from RSV, because standard centrifugation-based immunoadsorption procedures resulted in a large
degree of non-specific sedimentation of the vesicles in this fraction
(R. Hresko and M. Mueckler, unpublished observations). RSV and
SSV fractions isolated from IRM mutant- expressing 3T3L1
adipocytes were first subjected to immuno-enrichment using beads
coated with anti-Glut4 antibodies. This resulted in a.95%
recovery of Glut4 vesicles from the membrane fraction and
a.20-fold enrichment of Glut4 in the pellets (Figure 6). The
supernatants from this initial immunoadsorption reaction were
then cleared of .99% of Glut4 by two additional immunoadsoptions using anti-Glut4 magnetic beads. The supernatants obtained
after the third anti-Glut4 immunoadsorptions were then used to
immunoadsorb vesicles containing the Dsred-tagged IRM mutant.
The recovery of the IRM mutant after immuno-enrichment
(,60%) was less efficient than that for Glut4 for reasons that are
not evident.
The immuno-enriched Glut4 and IRM vesicles were then
subjected to high resolution nanospray liquid chromatographic
mass spectroscopy (nano-LC-MS) and the proteins present in each
fraction were identified using the sequential scheme outlined in
Figure S1. The results from two independent large-scale immunoenrichment preparations and three independent nano-LC-MS
analyses are summarized in Tables 1 and Table S1–3, which
identify the proteins significantly enriched in each of the 4 different
fractions (Glut4-SSV, Glut4-RSV, IRM-SSV, IRM-RSV) relative
to control IgG fractions (P,0.05) for which a minimum of 2
distinct peptides were identified. The Glut4-SSV, Glut4-RSV,
IRM-SSV, and IRM-RSV fractions contained 132, 127, 121, and
62 proteins, respectively, according to this analysis. The control
IgG immunoadsorptions identify only those contaminant proteins
that have a non-specific affinity for IgG. Consequently, many of
these proteins, especially those that show a,2-fold degree of
enrichment, are likely to be non-specific contaminants that are
relatively abundant and/or have a high affinity for lipid/protein
vesicles. This probably includes most of the proteins listed in the
‘‘Miscellaneous’’ category, especially those proteins that are known
residents of mitochondria or the endoplasmic reticulum. As
expected, Glut4 peptides were highly enriched in all 4 fractions
with very high levels of statistical significance, confirming the
efficiency of the immunoadsorption reactions (see Supplemental
Table 1–3 and Tables 1). Note that although endogenous wildtype Glut4 was very efficiently cleared from the IRM mutantenriched vesicle fractions, the ectopically expressed tagged IRM

Figure 3. L500 and L503 are critical for insulin-stimulated
translocation of Glut4 to the cell periphery. After co-expression
of wild-type Glut4/eGFP and the various mutants within the IRM region
of Glut4/Dsred using recombinant adenovirus infection, adipocytes
were serum starved for 2 hours, stimulated with 1 mM insulin for
30 minutes, washed with cold PBS, fixed with 4% paraformaldehyde,
and then subjected to confocal microscopy analysis. The red color in
the left panels represents mutants of Glut4-Dsred, the green color in the
middle panels represents wild type Glut4/eGFP, and the yellow color in
the right panels represents the colocalization of Glut4/eGFP and
mutated Glut4/Dsred. The images were taken approximately through
the middle of the cells and are representative of 4–5 independent
experiments. The scale bar represents 10 mm.
doi:10.1371/journal.pone.0068516.g003

visualized by deep etch electron microscopy. The SSV fractions
contained small vesicles of relatively uniform size (,100 nm),
many of which were labeled with gold particles directed against
either the endogenous wild type Glut4 (Figure 5a) or the
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Figure 4. The IRM mutant was preferentially localized to the RSV fraction with a different sedimentation pattern. IRM/dsred mutant(see Figure 1) infected adipocytes were serum starved overnight on day 8–9 post-differentiation and were then subjected to subcellular fractionation.
The proteins from the RSV or SSV subcellular fractions were separated by SDS-PAGE, and then subjected to immunoblot analysis. (A). A representative
western blot is shown on the left, and the quantification on the right shows the mean6SE from 3 independent experiments. ‘‘**’’ indicates P#0.01
compared with control endogenous wild type Glut4. The isolated SSV (B) and RSV (C) subcellular fractions were subjected to sucrose velocity gradient
analysis as described in ‘‘Experimental Procedures’’. The fractions were collected from the bottom of the gradients and subjected to total protein
quantification (left panels) or immunoblot analysis for endogenous wild-type Glut4 and the IRM mutant (upper pictures and lower quantifications).
The data shown are representative of 2 independent experiments.
doi:10.1371/journal.pone.0068516.g004

mutant shares peptides with the native wild type transporter that
were identified by the nano-LC-MS analyses, and the IRM
mutant does not react with the C-terminal Glut4 antibody.

PLOS ONE | www.plosone.org
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the Glut4 SSV fraction (traditionally referred to as the Glut4 low
density microsomal (LDM) fraction) has been previously characterized by proteomic and immunological analyses. Our results
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Figure 5. Immuno-gold electron microscopic localization of Glut4 and the IRM mutant in RSV and SSV vesicles. Control or IRM/dsred
mutant (see Figure 1)-infected 3T3-L1 adipocytes were serum starved overnight. The cell lysates were subjected to differential centrifugation and the
RSV and SSV fractions were used to immuno-adsorb endogenous Glut4-containing vesicles (A, C upper panel) or the exogenously expressed mutant
IRM-containing vesicles (B, D) onto glass chips. The attached vesicles were labeled with immunogold-conjugated antibodies (18 nm gold conjugated
anti-mouse IgG for Glut4 and 12 nm gold conjugated anti-rat IgG for the IRM mutant) and were then visualized by electron microscopy (see
‘‘Experimental Procedures’’). The scale bars represent 100 nm.
doi:10.1371/journal.pone.0068516.g005

confirm the presence of many proteins that have been reported to
be present in the Glut4-SSV fraction by numerous studies
[23,44,45] (proteins present in the Glut4-SSV fraction that have
not been reported in previous studies are marked with an asterisk
in Table S1). Among the best characterized of the known Glut4
vesicle proteins include sortilin, Glut1 (Slc2a1), mannose-6-P
receptor, insulin- responsive aminopeptidase (Lnpep), transferrin
receptor, IgF-II receptor, AS160 (TBC1D4), Vps45, carboxypeptidase D, Rab10, syntaxin16, syntaxin6, clathrin, and caveolin.
Not surprisingly, most of these proteins are also present in the
Glut4-RSV fraction (Table S2). The total RSV (‘‘HDM’’) fraction
is enriched in markers for early biosynthetic compartments and
probably contains compartments involved in the subcellular
sorting of proteins associated with Glut4 intracellular vesicles. Of
the 75 different proteins enriched at least 2-fold in either the
Glut4-SSV or Glut4-RSV fractions, 33 (44%) of these were shared
by the two compartments (see Figure 7).
Our previous studies demonstrated that the vast bulk of the
IRM mutant was present in relatively large vesicular structures
dispersed throughout the cytoplasm that lacked wild type Glut4 or
any of several markers for various subcellular membrane
compartments [34], suggesting that the mutant may be shunted
to or trapped in a previously uncharacterized membrane
compartment(s). The results shown in Figure 4 confirm the
enrichment of the IRM mutant in relatively large vesicles.
Interestingly, the IRM-SSV fraction, which contained only a
PLOS ONE | www.plosone.org

small quantity of the total IRM mutant protein, shares a few of the
well-characterized proteins present in the wild type Glut4-SSV
fraction, including the mannose-6-P receptor, syntaxin16, syntaxin6, transferrin receptor, and AS160 (see Table S3). Of the 104
different proteins expressed in the Glut4-SSV and/or IRM-SSV
fractions, 25 (24%) of these were shared by the two fractions
(Figure 7). Strikingly, the IRM-RSV fraction, which contains most
of the IRM mutant protein expressed in 3T3L1 adipocytes,
contained only 26 distinct proteins that were enriched .2-fold
relative to the IgG control (Table 1). A total of 90 different
proteins were enriched .2-fold in either the IRM-RSV and/or
IRM-SSV fractions, and only 4 of these (4.4%) were shared by
both fractions. Only 5 of 68 proteins (7.3%) were shared between
the Glut4-RSV and IRM-RSV fractions (Figure 7). Importantly,
the most thoroughly characterized proteins present in Glut4
storage vesicles, i.e, IRAP, AS160, and sortilin, were not detected
in the IRM-RSV fraction. The relatively small number of enriched
proteins in the IRM-RSV fraction and the small degree of overlap
in protein composition with the other three membrane fractions as
a whole suggest that this subcellular fraction may primarily
represent a single, distinct, membrane compartment.
Interestingly, the two proteins that have the greatest effect size
in the IRM-RSV fraction, a parameter based on relative peptide
intensities, are Ras GTPase binding proteins 1 and 2 (G3bp1 and
G3bp2). G3bp1 and G3bp2 are proteins with multiple RNA and
protein binding domains that are known to be involved in the
8
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was shown to recycle through the plasma membrane under basal
conditions and then to equilibrate with the bulk pool of
intracellular transporter molecules, whereas the IRM mutant
completely failed to recycle in the presence or absence of insulin.
This is by far the most dramatic phenotype ever reported for a
Glut4 trafficking mutant, suggesting that the IRM plays a
fundamental role, probably at an early stage, in the subcellular
sorting of Glut4 molecules in 3T3L1 adipocytes. It is important to
note that revealing the full extent of the aberrant phenotype of the
IRM mutant was dependent on the co-localization of the mutant
with a differentially tagged wild type Glut4 chimera co-expressed
in the same cell population. Simply comparing different cell
populations expressing either the wild type or IRM mutant would
not have clearly demonstrated the extreme degree of misstargeting of the mutant. Surprisingly, mutations in the IRM did
not discernibly affect the trafficking or insulin responsiveness of
IRAP. It is possible that IRAP ‘‘piggybacks’’ through the IRM
sorting step on another molecule, but that begs the question as to
why IRAP possesses the IRM sequence at all. Another possibility is
that the IRM functions at a different step in IRAP trafficking and
that mutations within the motif have a much more subtle
phenotype for IRAP. The IRM appears to constitutively facilitate
the trafficking of Glut4 to insulin responsive intracellular
membrane compartments. There is no evidence that recognition
of the IRM itself is regulated by the presence or absence of insulin.
It should also be mentioned that it is not know whether mutations
within the IRM affect transport activity of the protein, since IRM
mutants are never inserted into the plasma membrane.
In the present study we examined the properties of the IRM
mutant and the uncharacterized membrane compartments to
which it is targeted. Both L500 and L503 are critical determinants of
the IRM, since point mutations in either residue resulted in a
phenotype very similar to that exhibited by the original IRM
mutant. All 4 of the other residues within the IRM tolerate
mutation to alanine residues, although this observation by itself
does not negate the possibility that these residues do play a role in
the recognition of the IRM by targeting factors. These data
strongly suggest that mutations within the IRM do not result in the
fortuitous creation of a dominant trafficking motif that results in
the miss-targeting of Gut4, but that the IRM sequence comprises a
motif that is critical for the eventual movement of the transporter
into insulin responsive intracellular compartments. Because the
IRM mutant never appears to reach the plasma membrane either
in the presence or absence of insulin, it likely functions at a very
early stage of Glut4 sorting, perhaps at the TGN. This hypothesis
is also supported by data (X. Song and M. Mueckler,
unpublished), which demonstrate that the IRM motif acts in a
dominant fashion to the FQQI, di-leucine, or TELEY motifs when
mutations in two of the motifs are introduced into the same Glut4
molecule.
The IRM mutant was much more highly enriched in the RSV
fraction compared to wild type Glut4. When the RSV fraction was
analyzed by sucrose velocity gradient centrifugation, wild-type
Glut4 was present in two distinct peaks representing larger and
smaller vesicle populations. Presumably the smaller vesicles
associated with larger structures during the initial differential
centrifugation, but separated from the larger vesicles during the
velocity centrifugation step. In contrast, the IRM mutant was
present in a single broad peak near the bottom of the gradients,
representing a relatively large vesicle population. In the SSV
fraction, which contained a relatively small proportion of the total
IRM mutant, both endogenous wild type Glut4 and the mutant
were present in single peaks representing small vesicles. These
observations were confirmed and extended by immunogold

Figure 6. Immuno-adsorption of Glut4 and IRM mutant vesicles
for Mass Spectrometry. RSV and SSV vesicles were pre-cleared with
anti-rabbit IgG beads for 2 hours and the supernatant fractions were
immuno-adsorbed with polyclonal anti-Glut4 magnetic beads. The
supernatant fractions were subsequently subjected to immunoadsorption with anti Dsred beads (to adsorb the mutant-containing
vesicles). After washing, equal aliquots of the eluates from the beads
were subjected to SDS PAGE and then subjected to immuno-blotting
with monoclonal IF8 anti-Glut4 or anti-HA antibody (to detect the IRM
mutant).
doi:10.1371/journal.pone.0068516.g006

formation of RNA stress granules [46,47,48]. They are also
present in the cytosol and the nucleus but have not been previously
reported on cytoplasmic membrane structures or studied in
adipocytes [48,49]. We therefore examined their possible role in
the formation of the IRM vesicles in adipocytes. First, we
confirmed the co-localization of G3bp1 and G3bp2 with purified
IRM vesicles (Figure 8B). Next, we decreased expression of the
proteins in adipocytes infected with recombinant adenovirus
encoding the IRM mutant using siRNAs. Reducing G3bp1
and/or G3bp2 expression by 65–85% had no effect on the
distribution of wild-type Glut4 or the IRM mutant between the
RSV and SSV fractions and had no effect on the total expression
levels of either of the Glut4 proteins (Figure 9). Since IRM
expression did not alter the level of either G3bp1 or G3bp2
(Figures 8A), it appears that the IRM mutant either migrated to
pre-existing vesicles enriched in G3bp1 or that IRM expression
induced the partial migration of G3bp1/2 to a newly formed
membrane compartment.

Discussion
We previously reported the existence of a putative novel
subcellular trafficking motif in the cytoplasmic carboxyl-terminal
tail of the Glut4 glucose transporter (L500XXLXPDEXD509)
(where X is any amino acid) [34]. The motif was identified by
virtue of alignment with an identical sequence within the
cytoplasmic amino terminal domain of IRAP, which is present
in Glut4 storage vesicles and appears to share a very similar
insulin-regulated subcellular trafficking pattern with Glut4 in
adipocytes. Mutation of all 6 of the residues within this motif or of
L500, L503 and p505 together to alanine residues resulted in the
aberrant targeting of Glut4 in the basal state and totally abolished
insulin-stimulated translocation of the transporter to the plasma
membrane. Additionally, a fraction of intracellular wild type Glut4
PLOS ONE | www.plosone.org

9

July 2013 | Volume 8 | Issue 7 | e68516

Novel Glut4 Membrane Compartments

Table 1. Proteins Identified in the IRM Mutant RSV Fraction from 3T3-L1 Adipocytes by Nano-LC-MS.

Primary protein name

Effect Size

P Value

Protein Description

Solute carrier family 2, facilitated glucose transporter member 4

Membrane cargo proteins:
Slc2a4

5.86

1.75E-07

Scp2

3.04

4.51E-03

Non-specific lipid-transfer protein (EC 2.3.1.176) (NSL-TP) (Sterol carrier protein 2).

Atp6v1b2

2.44

6.00E-04

V-type proton ATPase subunit B, brain isoform

Igf2r

1.79

5.90E-03

Cation-independent mannose-6-phosphate receptor

Lrp1

1.75

1.49E-02

Prolow-density lipoprotein receptor-related protein 1

Anxa1

1.72

1.45E-04

Annexin A1

Anxa6

1.71

4.73E-09

Annexin A6

Anxa4

1.46

2.49E-02

Annexin A4

Atp5h

1.38

3.77E-03

ATP synthase, H+ transporting, mitochondrial F0 complex, subunit d (Fragment)

Slc25a5

1.27

3.48E-02

ADP/ATP translocase 2

Bone marrow stromal antigen 2

Membrane trafficking/sorting proteins
Bst2

3.46

1.27E-02

Naca

2.92

4.91E-04

Nascent polypeptide-associated complex subunit alpha, muscle-specific form

Dctn1

1.57

3.84E-02

Dynactin subunit 1

Scamp3

1.48

1.89E-02

Secretory carrier-associated membrane protein 3

Snares
Stx12

1.64

1.24E-02

Syntaxin-12

Vamp8

1.50

1.45E-02

Vesicle-associated membrane protein 8

Gapdh

3.05

2.63E-03

Glyceraldehyde-3-phosphate dehydrogenase

Pygb

1.64

1.95E-05

Glycogen phosphorylase, brain form

G3bp2

7.31

1.05E-05

Ras GTPase-activating protein-binding protein 2

G3bp1

6.68

1.09E-06

Ras GTPase-activating protein-binding protein 1

Cltc

1.46

1.04E-04

Clathrin heavy chain 1

Kinase and phosphatase

Coated and adaptor

Iqgap1

1.42

5.91E-03

Ras GTPase-activating-like protein IQGAP1

Mapksp1

1.37

1.90E-02

Mitogen-activated protein kinase scaffold protein 1

Secreted
Alb

3.48

5.98E-06

Serum albumin

Aimp1

3.23

6.02E-04

Aminoacyl tRNA synthetase complex-interacting multifunctional protein 1

Anxa2

1.31

4.63E-02

Annexin A2

Sptan1

2.16

5.73E-03

Spectrin alpha chain, brain

Myh9

2.06

2.62E-03

Myosin-9

Cytoskeletal

Vim

1.80

2.73E-05

Vimentin

Tuba1b

1.44

9.07E-03

Tubulin alpha-1B chain

Tubb5

1.19

2.40E-02

Tubulin beta-5 chain

Caprin1

3.71

7.88E-06

Caprin-1

Nudt21

3.56

1.09E-02

Cleavage and polyadenylation specificity factor subunit 5

Mrps36

3.33

3.46E-02

28S ribosomal protein S36, mitochondrial

Pabpc4

2.65

1.16E-02

Poly A binding protein, cytoplasmic 4

Psmd7

2.62

3.05E-02

26S proteasome non-ATPase regulatory subunit 7

Bckdha

2.62

9.76E-05

2-oxoisovalerate dehydrogenase subunit alpha, mitochondrial,

Bckdhb

2.56

4.51E-03

2-oxoisovalerate dehydrogenase subunit beta, mitochondrial

Psmd11

2.27

4.50E-03

26S proteasome non-ATPase regulatory subunit 11

Eef1d

2.25

1.03E-05

Elongation factor 1-delta

Timm44

2.24

2.77E-04

Mitochondrial import inner membrane translocase subunit TIM44

Miscellaneous
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Table 1. Cont.

Primary protein name

Effect Size

P Value

Protein Description

Fubp3

2.23

4.46E-02

Far upstream element (FUSE) binding protein 3

Decr1

2.20

9.04E-05

2,4-dienoyl-CoA reductase, mitochondrial

Ogdh

2.13

3.48E-02

2-oxoglutarate dehydrogenase E1 component, mitochondrial

Hnrnpa2b1

2.04

3.44E-02

Heterogeneous nuclear ribonucleoproteins A2/B1

Hadhb

1.88

4.57E-02

Trifunctional enzyme subunit beta, mitochondrial

Dld

1.79

2.13E-02

Dihydrolipoyl dehydrogenase, mitochondrial

Hsp90ab1

1.76

8.36E-04

Heat shock protein HSP 90-beta

Hadha

1.73

3.10E-03

Trifunctional enzyme subunit alpha, mitochondrial

Dctn2

1.72

1.15E-03

Putative uncharacterized protein

Pabpc1

1.72

6.33E-03

Polyadenylate-binding protein 1

Hbb-y

1.71

1.75E-02

Hemoglobin subunit epsilon-Y2

Glul

1.68

2.06E-02

Glutamine synthetase

2700060E02Rik

1.66

2.16E-03

UPF0568 protein C14orf166 homolog

Fasn

1.56

4.47E-03

Fatty acid synthase

Lamp2

1.49

2.94E-03

Lysosome-associated membrane glycoprotein 2

Cct2

1.45

3.78E-02

T-complex protein 1 subunit beta

Gpd1

1.42

4.66E-02

Glycerol-3-phosphate dehydrogenase [NAD+], cytoplasmic

Anxa5

1.34

4.29E-02

Annexin A5 (Lipocortin V) (Calphobindin I) (CBP-I) (Placental anticoagulant protein I).

Arl8b

1.32

2.12E-02

ADP-ribosylation factor-like protein 8B

Mdh2

1.27

1.67E-02

Malate dehydrogenase, mitochondrial precursor (EC 1.1.1.37).

The ‘‘Effect Size’’ represents the values relative to the corresponding IgG control group, the ‘‘P Value’’ represents the statistical significance of enrichment compared to
the corresponding IgG control groups.
doi:10.1371/journal.pone.0068516.t001

fraction in our analysis but are not listed in Table S1, because
their enrichment above the controls did not quite achieve
statistical significance. The previous proteomic studies did not
report the statistical analysis of multiple MS runs. It should be
noted that many if not most of the proteins identified by the MS
analysis were probably associated non-specifically with the
immunoadsorbed vesicles. For example, many resident mitochondrial proteins are listed in the tables that clearly cannot be
specifically associated with Glut4 or IRM vesicles. The control
fractions represent proteins that sediment with magnetic beads
coated with non-specific IgG, and thus the control immunoprecipitates contain a small non-specific membrane vesicle content
relative to the Glut4 and IRM mutant immuno-enriched fractions.
We would therefore expect proteins that have a high affinity for
membrane lipids per se to be enriched in the Glut4 and IRM
vesicles fractions relative to the control fractions. Also, highly
abundant proteins in general are more likely to be non-specifically
trapped and detected in the larger Glut4 and IRM bead pellets.
These are problems unique to the interpretation of proteomic
analyses of immuno-enriched membrane vesicle populations that
are well recognized and cannot be avoided.
Not surprisingly, 44% of the proteins in the Glut4-SSV fraction
were also detected in the Glut4-RSV fraction (often referred to as
the ‘‘high-density microsomal fraction’’). These two vesicle
fractions undoubtedly contain specific membrane compartments
that are precursors to compartments in the other fraction, either
during initial biosynthesis of Glut4 or during its steady state
intracellular recycling, and thus it is expected that they would
share many of the same proteins.
All of our data are consistent with the conclusion that only a
very small proportion of the IRM mutant is present in small

labeling following by examination of the RSV and SSV fractions
by deep etch electron microscopy. In the SSV fractions both wild
type Glut4 and the IRM mutant were observed in 50–100 nm
vesicles, and the abundance of vesicles was much lower on the
grids coated with antibodies that recognized the IRM mutant. The
Glut4-RSV fraction contained a mixture of small 50–100 nm
vesicles and large (150–250 nm) vesicles, the latter often either
associated with or consisting of branching structures. Interestingly,
Glut4 was relatively abundant on the surface of the branching
structures and was largely excluded from the bodies of the largest
vesicles. Glut4 labeling was also observed in the small vesicles of
the RSV fraction, which were abundant. In contrast, the IRMRSV fraction lacked branching structures and was much more
enriched in large vesicles (150–250 nm) compared to the Glut4RSV fraction. IRM mutant gold labeling was highly concentrated
on the surfaces of many of these large vesicles. It is tempting to
speculate that the labeled branching structures in the Glut4-RSVs
represent Glut4 moving through transitional membrane compartments, and that the large vesicles heavily labeled in IRM-RSVs
represent the mutant present in a static, ‘‘dead-end’’ membrane
compartment to which it is miss-targeted.
The 4 membrane fractions characterized in this study were
analyzed by a highly sensitive nano-LC-MS procedure in order to
define their protein compositions and characterize the compartments to which the IRM mutant was misdirected. The Glut4-SSV
fraction (originally termed the ‘‘low-density microsomal fraction’’)
has been subjected to proteomic analyses in two previous studies
[23,44]. Our data confirm the presence of most of the proteins
identified in these two studies (see Table S1), with a few notable
exceptions. For example, the previously identified proteins,
VAMP2, Rab4, and LRP1 were detected in the Glut4-SSV
PLOS ONE | www.plosone.org
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Figure 7. Diagram of the overlapping protein compositions of
the Glut4 and mutant IRM enriched vesicle fractions according
to nano-LC-MS analysis. Each number in the circle represents the
unique proteins in that fraction relative to the other. The underlined
numbers in overlapping areas between two circles represent the
number of shared proteins between the two fractions. The gray circle
represents Glut4-RSV, the blank circle represents Glut4-SSV, the small
gray shaded circle represents IRM-RSV, and the gray dotted circle
represents IRM-SSV.
doi:10.1371/journal.pone.0068516.g007

Figure 8. G3bp1/2 are present in immunoenriched IRM
vesicles. (A) Cell lysates from control or IRM/dsred expressing
adipocytes were subjected to differential centrifugation and the RSV
and SSV fractions were subjected to immunoblot analysis using the
antibodies indicated. (B) RSV fractions obtained as described above
were subject to immunoadsorption with anti-Dsred or control IgG
antibodies after pre-clearing endogenous Glut4 vesicles from the
fractions using anti-Glut4 antibody. The eluates from the beads
immuno-adsorbed with anti-IRM/dsred antibody or control IgG were
analyzed by immunoblot analysis with the indicated antibodies.
doi:10.1371/journal.pone.0068516.g008

membrane vesicles. The IRM-SSV fraction shares 25 proteins
with the Glut4-SSV fraction. This includes several proteins that
are known to recycle, including the transferrin and mannose-6-P
receptors [23,50]; AS160, (TBC1D4) a protein known to be
involved in the regulation of Glut4 trafficking [51]; and several
proteins previously identified in Glut4 membrane compartments,
including syntaxins 6 and 16, clathrin, and caveolin [33,52,53].
Interestingly, Cd36, a member of the class B family of scavenger
receptors, is also shared between the Glut4-SSV and IRM-SSV
fractions, but is much more highly enriched in the latter fraction.
CD36 is involved in the binding and uptake of a diverse set of
ligands, including long chain fatty acids, lipoproteins, collagen,
phospholipids, and thrombospondin [54,55]. The small proportion of the IRM mutant that appears in the SSV fraction may
represent some leakage of the mutant into authentic Glut4
membrane compartments, but the majority of proteins in the
Glut4-SSV and IRM-SSV fractions are not shared, suggesting that
most of the small vesicles containing the IRM mutant represent
one or more membrane compartments from which wild type
Glut4 is excluded. For example, Glut1 (SLC2a1) is highly enriched
in Glut4-SSV, but was not detected in IRM-SSV.
The vast bulk of the IRM mutant was detected in 150–250 nm
vesicles in the IRM-RSV fraction. This fraction possessed the
smallest number of proteins (26) that were .2-fold enriched of the
IgG control and also shared the fewest number of proteins by far
with the other fractions in pair wise comparisons (5 with Glut4RSV and 4 with IRM-SSV). Of these shared proteins, two were
shared with both Glut4-RSV and IRM-SSV (bone marrow
stromal antigen 2 and the beta subunit of the V-type proton
ATPase). These data strongly suggest that most of the IRM
mutant molecules are present in one or more membrane

PLOS ONE | www.plosone.org

Figure 9. siRNA-mediated knockdown of G3bp1/2 expression
does not affect levels of wild-type Glut4 or the IRM mutant in
RSV and SSV fractions. Two days after infection with recombinant
adenovirus expressing the IRM/dsred construct, the infected adippcytes
and non-infected control adipocytes were transfected with siRNA
directed against G3bp1 and/or G3bp2 mRNAs. After 2 h starvation, cell
lysates from non-infected control adipocytes or IRM/dsred expressing
adipocytes were subjected to differential centrifugation and the RSV
and SSV fractions along with total cellular homogenates were subjected
to immunoblot analysis using the antibodies indicated. Scrambled
siRNA was used as a control. The blot shown is representative of 3–4
independent experiments.
doi:10.1371/journal.pone.0068516.g009
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FIND(‘‘PE = ’’,
MID(AJ2,
FIND(‘‘GN = ’’,
AJ2)+LEN(‘‘GN = ’’),999))–1) where AJ2 is the cell where the protein
name exists. The spreadsheet was then sorted using Gene Symbol,
to group them accordingly. The gene-grouped peptide intensity
data were imported into DAnTE-R for statistical analysis [42,43]
(Step 8).
(TIF)

compartments from which wild type Glut4 and other resident
proteins of Glut4 vesicles are excluded.
The IRM-RSV fraction contains a heterogeneous mixture of
membrane proteins and proteins that associate with membranes in
various subcellular compartments. The 2 proteins that displayed
the greatest enrichment relative to the non-specific IgG -coated
beads were Ras GTPase-activating protein binding proteins 1 and
2 (G3bp1 and 2). Both G3bp-1 and G3bp2 are mRNA-binding
proteins that are present in cytoplasmic stress granules that
represent large clusters of mRNPS that are induced by various
types of cellular stress and are not bounded by membranes
[56,57]. The precise role of stress granules and of G3pb in their
formation is unclear. G3bps have also been associated with the
regulation of signaling by the Ras family of GTPases and have
been proposed to be involved in a variety of other cellular
functions [46,48,58]. One possible explanation for the association
of the IRM mutant with stress-granule associated proteins is that
the mutant is funneled into a pathway by which misfolded or mistargeted proteins are sequestered in a specific membrane
compartment, associated with stress granules, for subsequent
degradation. However, dozens of proteins have been identified in
stress granules, and only 3 of these appear to be associated with the
IRM compartment. An alternative explanation is that the
localization of G3bp1/2 to the IRM compartment may reflect a
currently unrecognized functional aspect of these proteins.

Figure S2 Flow Chart of Deep-Etch Electron Microscopy. Control or IRM mutant infected 3T3-L1 adipocytes were
serum starved overnight. The cellular homogenates were subjected
to subcellular fractionation and the RSV and SSV fractions were
used for immuno-adsorption with control IgG or anti-Glut4
polyclonal antibodies attached to magnetic beads in order to clear
the fractions by adsorption to non-specific IgG and/or to clear the
fractions of vesicles containing wild-type Glut4. After glass chips
were coated with either anti-Glut4 or anti-Dsred polyclonal
antibody, the endogenous Glut4-containing vesicles or the
exogenously expressed mutant IRM-containing vesicles were
immuno-adsorbed onto the coated glass chips (4). The vesicles
on the glass chips were fixed, probed with either mouse IF8 antiGlut4 monoclonal (for endogenous Glut4) or rat anti-Dsred
polyclonal antibody (for the IRM mutant), and then labeled with
immunogold-conjugated secondary antibodies (18 nm gold conjugated anti-mouse IgG for Glut4 and 12 nm gold conjugated
anti-rat IgG for the IRM mutant) and were then visualized by
electron microscopy (see ‘‘Experimental Procedures’’).
(TIF)

Supporting Information

Table S1 Identified proteins in Glut4 vesicles from SSV
in 3T3-L1 adipocytes. The ‘‘Log Effect’’ and ‘‘Effect Size’’
represent the value relative to the corresponding IgG control
group, the ‘‘P Value’’ represents the significance of enrichment
compared to corresponding IgG control groups.
(XLS)

Figure S1 Data processing for quantitative, label-free
proteomics analysis of immunoprecipitates. In step 1, the
unprocessed LC-MS/MS files that were acquired using X-calibur
(Thermofisher, ver. 2.0.7) were analyzed using Mascot Distiller
software (ver 2.0.3) for preparation of files for database searching.
After creating the *.mgf files, the MS2 data were searched using
MASCOT (ver. 2.2.04) [41] against the UNIPROT mouse
protein database (downloaded May 2011, with 135387 sequences)
(Step 2). The MS1 and MS2 mass tolerances were set at 20 ppm
and 0.8 Da, respectively. Carbamidomethyl was set as a fixed
modification for Cys residues and Met residue oxidation was
allowed as a variable modification. The protein database searches
were further analyzed using Scaffold software (ver. 3_00_07) (Step
3) and the proteins were identified using the Protein Prophet
algorithm [40] with protein and peptide thresholds of 95% and
50%, respectively (Step 4). The identified proteins and supporting
mass spectrometric data are given in Table S1. For relative
protein quantification, the same set of unprocessed LC-MS files
were imported into Rosetta ElucidatorTM (Rosetta Biosoftware,
ver 3.3) and the peptide ion chromatograms were aligned and
mean normalized using the following modification of the
previously described parameters [59]): ‘‘Peak time score minimum
= 0.5; peak m/z score minimum = 0.5; Scan width of m/z = 350–
1400; LC time range of 30–140 min; intensity scaling based on the
mean intensity of all features (Step 5). The aligned peptide ion
currents (PIC’s) were annotated within the software by generating
*.dta files (Step 6) and searching the UNIPROT human database
using MASCOT as described above (Step 7). The ion current
signals from all charge states for each peptide were concatenated
unique using a visual script within the software. The table of
peptides and peptide intensities was exported in Excel *.csv format
(Step 8). In order to group peptide data generated from the
products of each gene, the Mouse gene symbol was extracted from
the UniProt database protein descriptor for each identified
peptide. This was done using the following formula in Excel:
= LEFT(MID(AJ2, FIND(‘‘GN = ’’, AJ2)+LEN(‘‘GN = ’’),999),
PLOS ONE | www.plosone.org

Table S2 Identified proteins in Glut4 vesicles from RSV
in 3T3-L1 adipocytes. The ‘‘Log Effect’’ and ‘‘Effect Size’’
represent the value relative to the corresponding IgG control
group, the ‘‘P Value’’ represents the significance of enrichment
compared to corresponding IgG control groups.
(XLS)
Table S3 Identified proteins in IRM mutant vesicles
from SSV in 3T3-L1 adipocytes. The ‘‘Log Effect’’ and
‘‘Effect Size’’ represent the value relative to the corresponding IgG
control group, the ‘‘P Value’’ represents the significance of
enrichment compared to corresponding IgG control groups.
(XLS)
Table S4 Mass Spectrometry and Database Search
Results. Database: the uniprot-mouse_20101228 database
(Downloaded 5/2/2011, 135387 entries). Database searching:
MASCOT DISTILLER version 2.3.0.0; MASCOT version
2.2.04. Protein Identification/Spectral Counting Quantification;
Scaffold Proteome Software version 3.0.9.1.
(XLS)
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